EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine

Qigu Yao, Sheng Cheng, Qiaoling Pan, Jiong Yu, Guoqiang Cao, Lanjuan Li, Hongcui Cao

MedComm · 2024-10 · 5 (10)

DOI: 10.1002/mco2.735 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 21.09.2024. Verfasst von Qigu Yao und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases National Clinical Research Center for Infectious Diseases Collaborative I…. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 327 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Organoids are miniature, highly accurate representations of organs that capture the structure and unique functions of specific organs. Although the field of organoids has experienced exponential growth, driven by advances in artificial intelligence, gene editing, and bioinstrumentation, a comprehensive and accurate overview of organoid applications remains necessary. This review offers a detailed exploration of the historical origins and characteristics of various organoid types, their applications—including disease modeling, drug toxicity and efficacy assessments, precision medicine, and regenerative medicine—as well as the current challenges and future directions of organoid research. Organoids have proven instrumental in elucidating genetic cell fate in hereditary diseases, infectious diseases, metabolic disorders, and malignancies, as well as in the study of processes such as embryonic development, molecular mechanisms, and host–microbe interactions. Furthermore, the integration of organoid technology with artificial intelligence and microfluidics has significantly advanced large‐scale, rapid, and cost‐effective drug toxicity and efficacy assessments, thereby propelling progress in precision medicine. Finally, with the advent of high‐performance materials, three‐dimensional printing technology, and gene editing, organoids are also gaining prominence in the field of regenerative medicine. Our insights and predictions aim to provide valuable guidance to current researchers and to support the continued advancement of this rapidly developing field.

Schlagwörter

Stichwörter der Autor:innen

animal modelsdisease modeldrug screening organoidspersonalized medicine

Autor:innen und Institutionen

  • State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases National Clinical Research Center for Infectious Diseases Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases Na…
  • Zhejiang Key Laboratory for Diagnosis and Treatment of Physic-Chemical and Aging-Related Injuries Hangzhou China.

Förderung

  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Yao, Q., Cheng, S., Pan, Q., Yu, J., Cao, G., Li, L., & Cao, H. (2024). Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine. MedComm, 5(10). https://doi.org/10.1002/mco2.735

Vancouver

Yao Q, Cheng S, Pan Q, Yu J, Cao G, Li L, et al. Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine. MedComm. 2024;5(10). doi:10.1002/mco2.735

BibTeX
@article{Yao2024,
  author = {Yao, Qigu and Cheng, Sheng and Pan, Qiaoling and Yu, Jiong and Cao, Guoqiang and Li, Lanjuan and Cao, Hongcui},
  title = {Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine},
  journal = {MedComm},
  year = {2024},
  volume = {5},
  number = {10},
  doi = {10.1002/mco2.735}
}
Kostenlos starten →